CONSULTING GROUP CAPITAL MARKETS FUNDS
NSAR-A, EX-27, 2000-12-15
Previous: CONSULTING GROUP CAPITAL MARKETS FUNDS, NSAR-A, 2000-12-15
Next: BIOSPECIFICS TECHNOLOGIES CORP, 10QSB, 2000-12-15



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000875186
<NAME> Multi-Strategy Market Neutral Investments

<S>                             <C>
<PERIOD-TYPE>                  6-MOS
<FISCAL-YEAR-END>                               Mar-31-2001
<PERIOD-END>                                    Sep-30-2000
<INVESTMENTS-AT-COST>                            39,588,643
<INVESTMENTS-AT-VALUE>                           40,135,451
<RECEIVABLES>                                    27,007,920
<ASSETS-OTHER>                                    5,867,000
<OTHER-ITEMS-ASSETS>                                      0
<TOTAL-ASSETS>                                   73,010,371
<PAYABLE-FOR-SECURITIES>                            821,370
<SENIOR-LONG-TERM-DEBT>                                   0
<OTHER-ITEMS-LIABILITIES>                        26,966,407
<TOTAL-LIABILITIES>                              27,787,777
<SENIOR-EQUITY>                                           0
<PAID-IN-CAPITAL-COMMON>                         42,330,165
<SHARES-COMMON-STOCK>                             5,088,330
<SHARES-COMMON-PRIOR>                             3,899,768
<ACCUMULATED-NII-CURRENT>                         1,069,031
<OVERDISTRIBUTION-NII>                                    0
<ACCUMULATED-NET-GAINS>                           1,211,066
<OVERDISTRIBUTION-GAINS>                                  0
<ACCUM-APPREC-OR-DEPREC>                            612,332
<NET-ASSETS>                                     45,222,594
<DIVIDEND-INCOME>                                   276,013
<INTEREST-INCOME>                                   724,936
<OTHER-INCOME>                                            0
<EXPENSES-NET>                                      458,525
<NET-INVESTMENT-INCOME>                             542,424
<REALIZED-GAINS-CURRENT>                          1,020,291
<APPREC-INCREASE-CURRENT>                           590,205
<NET-CHANGE-FROM-OPS>                             2,152,920
<EQUALIZATION>                                            0
<DISTRIBUTIONS-OF-INCOME>                                 0
<DISTRIBUTIONS-OF-GAINS>                                  0
<DISTRIBUTIONS-OTHER>                                     0
<NUMBER-OF-SHARES-SOLD>                           3,340,112
<NUMBER-OF-SHARES-REDEEMED>                       2,151,550
<SHARES-REINVESTED>                                       0
<NET-CHANGE-IN-ASSETS>                           12,639,711
<ACCUMULATED-NII-PRIOR>                             526,607
<ACCUMULATED-GAINS-PRIOR>                           190,775
<OVERDISTRIB-NII-PRIOR>                                   0
<OVERDIST-NET-GAINS-PRIOR>                                0
<GROSS-ADVISORY-FEES>                               353,447
<INTEREST-EXPENSE>                                        0
<GROSS-EXPENSE>                                     443,028
<AVERAGE-NET-ASSETS>                             35,569,895
<PER-SHARE-NAV-BEGIN>                                 8.360
<PER-SHARE-NII>                                       0.130
<PER-SHARE-GAIN-APPREC>                               0.400
<PER-SHARE-DIVIDEND>                                  0.000
<PER-SHARE-DISTRIBUTIONS>                             0.000
<RETURNS-OF-CAPITAL>                                  0.000
<PER-SHARE-NAV-END>                                   8.890
<EXPENSE-RATIO>                                        2.59



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission